Stratec SE (0RAR.L)
EUR 23.01
(-0.01%)
EUR 23.01
(-0.01%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 80.8 Million EUR | 0.92% |
| 2022 | 80.06 Million EUR | 1.91% |
| 2021 | 78.56 Million EUR | -24.66% |
| 2020 | 104.27 Million EUR | 16.11% |
| 2019 | 89.8 Million EUR | 31.06% |
| 2018 | 68.52 Million EUR | 11.36% |
| 2017 | 61.53 Million EUR | 1927.48% |
| 2016 | 3.03 Million EUR | -29.88% |
| 2015 | 4.32 Million EUR | -3.46% |
| 2014 | 4.48 Million EUR | -32.52% |
| 2013 | 6.64 Million EUR | -10.94% |
| 2012 | 7.45 Million EUR | 745899900.0% |
| 2011 | 1.00 EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | -100.0% |
| 2005 | 2.12 Million EUR | -11.34% |
| 2004 | 2.39 Million EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 93.63 Million EUR | -3.34% |
| 2024 Q2 | 96.86 Million EUR | 5.29% |
| 2024 Q1 | 92 Million EUR | 13.86% |
| 2023 Q3 | 95.13 Million EUR | 1.31% |
| 2023 FY | 80.8 Million EUR | 0.92% |
| 2023 Q1 | 85.24 Million EUR | 6.47% |
| 2023 Q2 | 93.91 Million EUR | 10.16% |
| 2023 Q4 | 80.8 Million EUR | -15.07% |
| 2022 FY | 80.06 Million EUR | 1.91% |
| 2022 Q1 | 85.83 Million EUR | 9.25% |
| 2022 Q2 | 84.69 Million EUR | -1.33% |
| 2022 Q3 | 83.23 Million EUR | -1.72% |
| 2022 Q4 | 80.06 Million EUR | -3.81% |
| 2021 Q1 | 104.5 Million EUR | 0.22% |
| 2021 FY | 78.56 Million EUR | -24.66% |
| 2021 Q2 | 99.8 Million EUR | -4.5% |
| 2021 Q3 | 91.24 Million EUR | -8.58% |
| 2021 Q4 | 78.56 Million EUR | -13.9% |
| 2020 FY | 104.27 Million EUR | 16.11% |
| 2020 Q1 | 104.41 Million EUR | 16.27% |
| 2020 Q2 | 98.45 Million EUR | -5.71% |
| 2020 Q3 | 103.57 Million EUR | 5.21% |
| 2020 Q4 | 104.27 Million EUR | 0.67% |
| 2019 FY | 89.8 Million EUR | 31.06% |
| 2019 Q3 | 89.09 Million EUR | 7.64% |
| 2019 Q2 | 82.77 Million EUR | 10.58% |
| 2019 Q4 | 89.8 Million EUR | 0.8% |
| 2019 Q1 | 74.85 Million EUR | 9.23% |
| 2018 Q1 | 60.47 Million EUR | -1.71% |
| 2018 FY | 68.52 Million EUR | 11.36% |
| 2018 Q4 | 68.52 Million EUR | 14.25% |
| 2018 Q2 | 60.38 Million EUR | -0.16% |
| 2018 Q3 | 59.97 Million EUR | -0.67% |
| 2017 Q1 | 3.98 Million EUR | 31.27% |
| 2017 FY | 61.53 Million EUR | 1927.48% |
| 2017 Q4 | 61.53 Million EUR | -2.07% |
| 2017 Q3 | 62.83 Million EUR | 1835.71% |
| 2017 Q2 | 3.24 Million EUR | -18.52% |
| 2016 Q4 | 3.03 Million EUR | -22.46% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 4.23 Million EUR | 0.0% |
| 2016 FY | 3.03 Million EUR | -29.88% |
| 2016 Q3 | 3.91 Million EUR | -7.6% |
| 2015 Q4 | 4.32 Million EUR | 11.2% |
| 2015 Q1 | 4.03 Million EUR | -10.08% |
| 2015 FY | 4.32 Million EUR | -3.46% |
| 2015 Q2 | 3.78 Million EUR | -6.18% |
| 2015 Q3 | 3.89 Million EUR | 2.91% |
| 2014 Q3 | 5.4 Million EUR | -3.61% |
| 2014 FY | 4.48 Million EUR | -32.52% |
| 2014 Q1 | 5.8 Million EUR | -12.55% |
| 2014 Q4 | 4.48 Million EUR | -17.0% |
| 2014 Q2 | 5.6 Million EUR | -3.55% |
| 2013 Q3 | 6.94 Million EUR | 5.27% |
| 2013 Q1 | 6.71 Million EUR | -9.96% |
| 2013 FY | 6.64 Million EUR | -10.94% |
| 2013 Q4 | 6.64 Million EUR | -4.39% |
| 2013 Q2 | 6.6 Million EUR | -1.73% |
| 2012 Q3 | - EUR | 0.0% |
| 2012 Q4 | 7.45 Million EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 Q1 | - EUR | -100.0% |
| 2012 FY | 7.45 Million EUR | 745899900.0% |
| 2011 Q4 | 9.16 Million EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q1 | - EUR | -100.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q1 | - EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 Q4 | 7.42 Million EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | -100.0% |
| 2005 FY | 2.12 Million EUR | -11.34% |
| 2004 FY | 2.39 Million EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Cegedim SA | 188.54 Million EUR | 57.146% |
| Guerbet SA | 360.51 Million EUR | 77.588% |
| Nexus AG | 15.43 Million EUR | -423.384% |
| Bastide Le Confort Médical SA | 291.04 Million EUR | 72.238% |
| Revenio Group Oyj | 10.05 Million EUR | -703.98% |
| Drägerwerk AG & Co. KGaA | 257.71 Million EUR | 68.647% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 98.391% |
| LNA Santé SA | 341.16 Million EUR | 76.316% |
| Siemens Healthineers AG | 436 Million EUR | 81.468% |
| Medios AG | 14.65 Million EUR | -451.348% |
| Equasens Société anonyme | 39.51 Million EUR | -104.469% |